137 E Franklin St Suite 611, Chapel Hill, NC 27516
+613 3827 6693
Pain research, tips, and insights from renowned experts.
Biological basis of cannabinoid medicines
Mechanistic insights into cannabinoid signaling could improve therapeutic applications.
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. Numerous CBD products are available, ranging from a US Food and Drug Administration (FDA)-approved product called Epidiolex to products created for medical marijuana dispensaries and products sold in smoke shops, convenience stores, and over the Internet.
Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings
Cannabinoids have a long record of recreational and medical use and become increasingly approved for pain therapy. This development is based on preclinical and human experimental research summarized in this review.
Largest cannabinoid trial on pain finds significant improvement
Radicle Science and Open Book Extracts release results of the largest ever blinded, randomized clinical trial on cannabinoids and pain—and the first study of its kind to examine the impact of rare cannabinoids.
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
CBD’s potential to reduce cue-induced craving and anxiety provides a strong basis for further investigation of this phytocannabinoid as a treatment option for opioid use disorder.
Setting the standard of patient care through precision cannabinoid products.
© All Rights Reserved, ExstoBio
site by peques +co.